(Updated - March 1, 2017 7:39 AM EST)Jefferies lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $27.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE